FIGURE

Fig. 4

ID

ZDB-FIG-190724-18

Publication

Seda et al., 2019 - An FDA-Approved Drug Screen for Compounds Influencing Craniofacial Skeletal Development and Craniosynostosis

Other Figures

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 6
Fig. 8
Fig. 9

All Figure Page

Back to All Figure Page

Fig. 4

Examples of drug re-testing on wild-type zebrafish. Alcian blue-stained zebrafish at 5 days post-fertilisation showing jaw cartilage following drug treatment from embryonic day (E) 50 (A, A') or 29 hours post-fertilisation (hpf) (B, B'). A, B Ventral views. B, B' Lateral views of the same animals

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Mol. Syndromol.